World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Tesorai Raises $5.3 Million to Put Vast Troves of Untapped Research Data to Work

Cision PR Newswire by Cision PR Newswire
November 18, 2026
in Press Releases
Reading Time: 6 mins read
0
Share on FacebookShare on Twitter

The AI platform from former Google and Verily leaders processes raw data from new and past experiments, so researchers can test findings against existing evidence and train AI models on it

SAN DIEGO, Nov. 18, 2026 /PRNewswire/ — Tesorai, an AI company building a searchable knowledge layer for life sciences, today announced $5.3 million in seed funding, bringing its total funding to $8 million. Its AI analyzes raw data from new lab experiments and thousands of past ones so scientists can build on it and AI models can learn from it. In August, Tesorai’s team recovered a key Alzheimer’s marker from the raw data of five published brain studies, none of which had previously reported it. Tesorai will use the funding to expand work with biopharmaceutical and research customers, grow partnerships across the life sciences tools industry, and extend its platform beyond proteins to other kinds of molecular data. Investors in the round include Perplexity Fund, IQT, South Central Ventures, New Stack Ventures, NextGen Venture Partners, f7 Ventures, VitalStage Ventures, and ZAKA.

AI models of biology are limited by the experimental data they learn from, and funders are now paying to produce more. On Oct. 7, Biohub, Google DeepMind, Meta, Isomorphic Labs, and U.S. agencies announced a $1.8 billion effort to generate and standardize biological data for AI. Tesorai complements these efforts by starting with data that already exists, reprocessing and harmonizing thousands of publicly available datasets to recover information that was previously missed and make it available to scientists and AI developers.

Raw data from millions of experiments sits scattered across public repositories, institutional archives, and company databases, processed with different methods and often poorly annotated. Rather than simply indexing papers or aggregating existing analyses, Tesorai’s AI goes back to that raw data, which holds far more information than older analysis methods could accurately and quickly extract, and harmonizes the results across studies so researchers can search and compare them.

The result is a new way for researchers to interact with scientific knowledge: asking questions not just about what has been published, but about what the experiments themselves reveal. Tesorai Search processes that data in the cloud, whether it comes from a lab’s newest experiment or a study published years ago, and its patented model has processed thousands of files and terabytes of data in just a few hours, which previously required months to complete. Tesorai Chat runs downstream analyses using conversational prompts, a task that usually requires bioinformaticians, and Tesorai Trove empowers researchers to validate and cross-analyze their results against tens of thousands of past studies.

“Life science R&D is accelerating and becoming increasingly autonomous, which makes it more important to extract as much insight as possible from every experiment,” said Charlie Kim, co-founder and chief scientific officer of Tesorai. “Tesorai does this for a lab’s new data and for thousands of published studies. The gains compound as each experiment builds on the last, and ultimately, this helps the industry develop better medicines and products, faster.”

The potential of this approach is already becoming tangible. To test the Alzheimer’s panel, published in JAMA Neurology on Aug. 10, Tesorai’s team reprocessed raw files from five public brain studies and recovered p-tau217, one of the panel’s seven proteins and a leading Alzheimer’s marker, which none of the original studies had previously reported. It posted the analysis as a preprint three weeks later.

“Every experiment produces far more data than its paper can report, and most of it is never revisited,” said Melissa Miao, co-founder and CEO of Tesorai. “Our platform reclaims the value of experiments that have already been done and amplifies each new experiment with the relevant evidence that already exists.”

Tesorai’s processed data can also help train AI models of biology. In an August preprint, its researchers reported that adding protein data let a small single-cell AI model match or beat larger models trained only on RNA data, including one more than 40 times its size, on multiple benchmarks.

“The quality of data and metadata a model learns from can matter as much as the size of the dataset, and much of the data that biology’s AI models need has already been collected. Yet only a small fraction of it is readily accessible, harmonized, and usable today,” said Peter Cimermancic, co-founder and chief technology officer of Tesorai.

Miao, Peter Cimermancic, co-founder and chief technology officer, and Charlie Kim, co-founder and chief scientific officer, worked together at Verily, Alphabet’s life sciences company, where Kim launched and led the Molecular Science program, Miao led business initiatives and strategic partnerships, and Cimermancic led AI teams. Since raising a pre-seed round, Tesorai has signed contracts with biopharmaceutical and research organizations, collaborated with leading research institutions including MD Anderson Cancer Center, NYU, and the Michael J. Fox Foundation, and received its first U.S. patent, for one of its AI models.

“AI has the potential to dramatically accelerate scientific research, but its impact will depend on access to high-quality experimental data,” said Joanna Lee Shevelenko, co-founder and general partner of Perplexity Fund. “Tesorai is building the infrastructure to make that data usable at scale, giving scientists and AI systems a stronger foundation for advancing research.”

“Labs are generating more experimental data than ever, but its full value depends on processing that data efficiently,” said Tatjana Zabasu Mikuž, managing partner at South Central Ventures. “Tesorai’s team has built AI that does that at scale, for the experiments labs run today and the thousands already sitting in public archives.”

Beyond new kinds of molecular data, Tesorai plans to catalog more public repositories and supply processed data to companies building AI models of biology. Researchers can try the platform for free at www.tesorai.com.

About Tesorai
Tesorai builds AI tools that help scientists get more out of molecular data and accelerate research. Its platform includes Tesorai Search, which processes raw mass spectrometry data and was peer-reviewed in the Journal of Molecular Biology; Tesorai Trove, an AI-ready catalog of thousands of curated, structured public proteomics datasets; and Tesorai Chat, which lets researchers run analyses through an intuitive chat interface or through a connector to LLMs. Biopharmaceutical companies and research institutions use Tesorai for discovery, biomarker validation, and product characterization, and its structured data can accelerate training and improve performance of AI models of biology. Founded by former Google and Verily leaders, Tesorai is headquartered in San Diego. Learn more at www.tesorai.com.

Media Contact
Melissa Miao
427350@email4pr.com
415-501-0479

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tesorai-raises-5-3-million-to-put-vast-troves-of-untapped-research-data-to-work-302944021.html

SOURCE Tesorai

Cision PR Newswire

Cision PR Newswire

Related Posts

Weatherford Capital Expands Sports Investment Team, Names Grant Roach as Vice President

November 18, 2026

Istituto Milton Friedman: Since 2022, Russia’s largest private companies have been passing to new owners at discounts of up to 90%

November 18, 2026

West Cary Group Taps Rob Lankford to Connect Data, Creativity and Business Growth

November 18, 2026

Newmark Investor Solutions Launches Hotel Asset Management Business Led by Industry Veterans Dan Falvey and Steve Kakaty

November 18, 2026

Union Home Mortgage Expands Credit Evaluation Options by Accepting VantageScore 4.0

November 18, 2026

After 15 years explaining benefits, Jellyvision now runs them: ALEX Home benefits administration is live

November 18, 2026

Popular News

  • Weatherford Capital Expands Sports Investment Team, Names Grant Roach as Vice President

    0 shares
    Share 0 Tweet 0
  • Tesorai Raises $5.3 Million to Put Vast Troves of Untapped Research Data to Work

    0 shares
    Share 0 Tweet 0
  • Newmark Investor Solutions Launches Hotel Asset Management Business Led by Industry Veterans Dan Falvey and Steve Kakaty

    0 shares
    Share 0 Tweet 0
  • West Cary Group Taps Rob Lankford to Connect Data, Creativity and Business Growth

    0 shares
    Share 0 Tweet 0
  • Istituto Milton Friedman: Since 2022, Russia’s largest private companies have been passing to new owners at discounts of up to 90%

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler